For the Quarter Ending June 2025
North America
• The Vitamin B6 Spot Price in North America has witnessed a sharp decline of -5.74% in June 2025 and settled at USD 23,160/MT (CFR Los Angeles) which indicated a significant deterioration in demand-side momentum.
• Why did the price change in July 2025? The Vitamin B6 Price Index experienced continued pressure in July due to persistent oversupply from exporting origins, high domestic inventories and cautious procurement ahead of Q3. The market saw minimal price support from downstream sectors which led to another round of competitive pricing adjustments by importers.
• Uninterrupted production at Asian manufacturing hubs and strategic offer reductions by exporters led to consistent weekly declines in the Vitamin B6 Spot Price. U.S. importers were forced to match these offers, driving down CFR values.
• Distributors in the U.S. faced elevated inventory levels through June. The downstream pharmaceutical and nutraceutical sectors operated on deferred buying patterns, waiting for Q3 to initiate new orders.
• While domestic logistics and freight rates remained stable, they had minimal impact on pricing. The Vitamin B6 Price Forecast was shaped entirely by demand inertia and importer hesitation rather than logistical or policy-driven disruptions.
• Earlier in Q2, the market saw mild upward movement of +0.74% in April and +0.78% in May, supported by stable procurement and tight inventory discipline. However, the foundation for a Q3 decline was being laid.
• No uptick in consumption trends was seen across vitamin blends, fortified food, or contract formulations. Buyers relied on inventory drawdowns rather than initiating forward stocking.
• The Vitamin B6 Price Forecast for Q3 remains soft unless there is a revival in nutraceutical or pharmaceutical sector restocking. Price floors are being tested amid intense supplier competition.
• The U.S. market’s reliance on imports from Asia leaves it vulnerable to global oversupply trends, especially when domestic buying sentiment is suppressed.
Asia Pacific
• The Vitamin B6 Spot Price in APAC (FOB Shanghai) fell by -6.05% in June 2025, closing at USD 22,970/MT, marking the steepest monthly drop in Q2 due to unrestrained output and surplus inventory.
• Why did the price change in July 2025? The Vitamin B6 Price Index remained under pressure in July as Chinese producers continued discounting to clear high warehouse stocks. Global buyers avoided forward orders, expecting further price erosion amid continued oversupply.
• Throughout June, Chinese producers operated without interruptions, building up inventories. Weekly price cuts were deployed to prompt demand but achieved limited success.
• International and domestic buyers stayed on the sidelines, reluctant to purchase amid weekly price markdowns. No seasonal triggers or promotional cycles influenced spot demand.
• The Vitamin B6 price slide in APAC was purely market-driven, not logistical. Smooth port operations and domestic transportation facilitated exports, but the weak demand made these advantages irrelevant to price support.
• Prices saw modest gains in April (+0.75%) and May (+0.70%), driven by balanced production and consistent downstream procurement. However, this momentum reversed sharply in June.
• Despite weak maize sentiment globally, Chinese plants ran at full capacity, indicating no cost-side constraints. This ensured an uninterrupted supply glut, intensifying the price correction.
• APAC is expected to remain in a bearish posture for early Q3 unless corrective production cutbacks occur or demand revives from global formulation centers.
• With Chinese Vitamin B6 setting the global tone, FOB prices from Shanghai directly impacted CFR prices in both Europe and North America, reinforcing the interconnectedness of the supply-demand imbalance.
Europe
• The Vitamin B6 Spot Price in Europe (CFR Hamburg) dropped significantly by -5.95% in June 2025, closing at USD 23,080/MT, reflecting aggressive offshore supplier competition and stock-led demand weakness.
• Why did the price change in July 2025? The Vitamin B6 Price Index in July further deteriorated due to persistent exporter markdowns and subdued German demand. Elevated inventories discouraged restocking, and the absence of sector-specific events meant spot purchases remained minimal.
• Consistent production at exporting origins and absence of supply-chain bottlenecks created a seller-heavy market. Importers in Germany received lower offers weekly through June, forcing downward alignment on CFR pricing.
• German importers entered June with high stock levels, dampening procurement appetite. This inventory overhang created a psychological price ceiling across the market.
• The Vitamin B6 Spot Price rose modestly in April (+0.91%) and May (+0.70%), aligned with Chinese FOB trends. But these gains were undone in June as export offers weakened and demand slowed.
• Hamburg and other entry points saw seamless operations. Inland distribution faced no hurdles, and freight fluctuations remained secondary to price war-driven supply pressure.
• The pharmaceutical and supplement markets displayed no promotional triggers or seasonal restocking needs. Contract manufacturers operated on steady consumption patterns, avoiding speculative buying.
• Price recovery in Q3 will hinge on clearing existing inventories and any surprise uptick in EU demand. For now, the trajectory points downward or flat at best.
• Europe’s Vitamin B6 market continues to shadow Asian price benchmarks, with Chinese export sentiment and biofermentation trends setting the tone for Hamburg’s price index shifts.
For the Quarter Ending March 2025
North America
During the January to March 2025 quarter, the North American Vitamin B6 market experienced a modest average price increase of about 0.51% from previous quarter. The market tone was generally steady and was driven by stable demand from pharmaceutical and personal care sectors. Seasonal change from winter to early spring supported moderate procurement activity as manufacturers planned ahead for new production cycles.
Despite a relatively calm trading environment the tariff measures on certain imported categories provided some price support for locally sourced Vitamin B6. Inventory levels remained comfortably placed, with no significant overhang from the previous quarter. This allowed Vitamin B6 suppliers and Vitamin B6 distributors to manage supply efficiently without causing sharp market reactions.
The nutraceutical segment maintained steady offtakes, whereas the food and beverage sector operated cautiously amid controlled purchasing schedules. Overall, the combination of seasonal transition and steady downstream consumption helped Vitamin B6 prices hold firm in the region. Market sentiment remained optimistic throughout the first quarter of 2025 which was supported by consistent logistics and strategic buying across key sectors.
Asia Pacific
In the first quarter of 2025, the Asia Pacific market recorded a slight rise of around 0.90% in average Vitamin B6 prices. The period was marked by moderate activity in the Vitamin B6 market, with some support coming from downstream demand in pharmaceutical and nutraceutical sectors. The seasonal transition from winter to spring played a subtle role in shifting procurement patterns. Many Vitamin B6 suppliers in the region kept inventory levels steady and avoided large stock movements during the Chinese Lunar New Year holidays, which affected overall production schedules.
Being a key exporting country, any production adjustment in China typically influences the broader Asia Pacific Vitamin B6 market sentiment. The downstream sectors saw a stable performance, though food and beverage manufacturers showed slightly cautious buying due to existing stock availability. Smooth logistics and well-managed inventory positions limited any sharp fluctuations. Anticipation of upcoming production cycles further encouraged strategic procurement by Vitamin B6 distributors. Overall, the market followed a balanced pace in the first quarter of 2025, with steady price growth reflecting well-maintained market fundamentals.
Europe
The European market saw a mild quarterly increase of around 0.37% in Vitamin B6 prices during the first quarter of 2025. The region observed steady procurement patterns from pharmaceutical and food-related sectors, whereas personal care applications remained moderately active. A balanced supply situation, combined with controlled inventory positions helped in keeping market sentiment stable.
Many Vitamin B6 distributors in the region adopted a careful procurement approach and avoided excess stock build-up while maintaining essential supplies. Although the increase was marginal, it reflected consistent demand, particularly from nutraceutical manufacturers who planned ahead for seasonal product launches.
The overall Vitamin B6 market in Europe was shaped by steady logistics and anticipation of upcoming production schedules in key manufacturing hubs. Market players responded cautiously which helped to keep price movements limited within a narrow range. The price increase aligned with soft regional demand and balanced stock levels, helping the market avoid any volatility. As downstream sectors continued routine operations in first quarter of 2025, the market kept a composed tone with suppliers managing offers in line with stable regional trends.
For the Quarter Ending December 2024
North America
During Q4 2024, the Vitamin B6 market in North America maintained relative stability with a slight downward bias. October saw prices holding steady as balanced supply-demand fundamentals prevailed in the market. Buyers maintained routine procurement patterns while manufacturers reported normal operating rates. The nutraceutical and animal feed sectors continued their consistent demand, helping maintain price levels with only marginal softening.
November continued the stable trend with a slight downward movement as market fundamentals remained largely unchanged. Supply chains operated smoothly while demand from end-users remained consistent. Buyers continued their regular procurement activities, though some negotiated minor price concessions. Distributors reported comfortable inventory positions, leading to small price adjustments downward. The market witnessed systematic trading activity as end-users maintained routine buying patterns.
December saw the continuation of stable to soft pricing as year-end activities proceeded normally. Domestic suppliers maintained steady production rates, though facing minimal pressure to adjust prices marginally downward. The market demonstrated typical year-end patterns with slight price erosion, as buyers maintained regular consumption rates. Manufacturers reported balanced supply-demand conditions, with minor price adjustments reflecting the marginally softer market sentiment through quarter-end.
APAC
In Q4 2024, Vitamin B6 prices in APAC markets showed stability with a gentle downward trend. October maintained steady price levels as manufacturers balanced production with market requirements. Producers reported stable production costs, while consistent inquiries from various sectors helped maintain overall price levels with minimal decline. The market witnessed regular trading activity as buyers followed established procurement patterns.
November saw prices continuing their stable to soft trend. Manufacturers maintained steady operations while managing minor downward price adjustments amid adequate supply conditions. Regional trading activity proceeded at routine levels, with slight price concessions offered by suppliers. Production facilities reported normal operations, while export inquiries remained steady despite the marginal price decline.
December maintained the stable to soft trend as manufacturers continued routine operations. Several facilities reported normal production rates amid typical year-end demand. Export prices showed minimal softening, influenced by steady but slightly weaker inquiry levels from international markets. The domestic market maintained its usual vigor despite marginal price erosion, as end-users continued regular procurement patterns.
Europe
In Q4 2024, Vitamin B6 prices in Germany and broader European markets demonstrated similar stability with slight softening. October began with steady price levels as the market maintained equilibrium between supply and demand. European producers operated at normal rates while managing minor downward price adjustments. The market witnessed routine trading as distributors maintained regular procurement patterns.
November continued the stable trend with marginal price decline as market conditions remained balanced. Buyers maintained regular procurement while negotiating slight price reductions amid adequate supply availability. The market witnessed normal trading as distributors followed established buying patterns. Several buyers reported comfortable stock positions, contributing to the minimal downward price pressure.
December's market dynamics remained largely unchanged, though with continued slight softening. Regular consumption patterns across end-use sectors helped maintain overall stability, despite minor price erosion through quarter-end. Year-end activities proceeded normally, with key buyers maintaining routine procurement volumes. Manufacturers reported steady operations and well-managed inventory positions, while logistics activities continued smoothly through the holiday season, with prices showing minimal decline.
FAQs
1. What is Vitamin B6 and why is it important?
Vitamin B6, also known as pyridoxine, is a water-soluble vitamin essential for amino acid metabolism, neurotransmitter synthesis, immune function, and red blood cell production. It plays a critical role in converting food into energy and supporting brain health.
2. What are the main sources of Vitamin B6?
Dietary sources of Vitamin B6 include poultry, fish, bananas, fortified cereals, potatoes, and legumes. It is also available in pharmaceutical and nutraceutical formulations in synthetic or bioactive forms.
3. Which industries use Vitamin B6 as a key input?
Vitamin B6 is used extensively in the pharmaceutical, nutraceutical, animal feed, and fortified food industries. It is incorporated in multivitamin tablets, energy supplements, premixes for livestock, and therapeutic preparations for neurological and metabolic conditions.
4. What factors influence the global price of Vitamin B6?
The market price of Vitamin B6 is influenced by feedstock costs (such as glucose or petroleum derivatives), production dynamics in major manufacturing hubs like China, global regulatory requirements, and seasonal demand patterns from end-user industries.
5. Is there any difference between pyridoxine hydrochloride and other Vitamin B6 derivatives?
Yes. Pyridoxine hydrochloride is the most commonly used and stable form of Vitamin B6 in industrial applications. Other forms like pyridoxal and pyridoxamine exist but are less widely used due to stability and formulation constraints.
